Symbols / KYTX $8.98 +1.24% Kyverna Therapeutics, Inc.

Healthcare • Biotechnology • United States • NMS
KYTX Chart
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 542.89M
Enterprise Value 286.02M Income -161.31M Sales
Book/sh 3.85 Cash/sh 4.62 Dividend Yield
Payout 0.00% Employees IPO
P/E Forward P/E -3.15 PEG
P/S P/B 2.33 P/C
EV/EBITDA -1.70 EV/Sales Quick Ratio 7.65
Current Ratio 7.75 Debt/Eq 12.50 LT Debt/Eq
EPS (ttm) -3.64 EPS next Y -2.85 EPS Growth
Revenue Growth Earnings 2026-05-13 ROA -35.47%
ROE -64.67% ROIC Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 60.46M
Shs Float 35.12M Short Float 10.00% Short Ratio 7.19
Short Interest 52W High 13.67 52W Low 1.78
Beta 2.64 Avg Volume 724.00K Volume 537.02K
Target Price $29.60 Recom Strong_buy Prev Close $8.87
Price $8.98 Change 1.24%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
Mean price target
2. Current target
Latest analyst target
3. DCF / Fair value
$-27.42
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
Low
High
Mean

No recent news from Yahoo. Try the RSS feed for latest KYTX news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-13 GRASSO MARC Chief Financial Officer 10,000 $0.00 $0
2026-03-13 BIDDLE WARNER WESTON Chief Executive Officer 58,000 $0.00 $0
2026-03-13 GEHCHAN NAJI M.D. Officer 18,000 $0.00 $0
2026-02-24 MILLER ANDREW CRAIG Director 11,006 $0.00 $0
2026-02-24 EMANY SRAVAN KUMAR Director 11,006 $0.00 $0
2026-01-12 SHAW CHRISTI L Officer and Director 54,301 $0.00 $0
2025-12-18 SEIDENBERG BETH C Director 133,333 $7.50 $999,998
2025-12-18 WESTLAKE BIOPARTNERS FUND I, L.P. Beneficial Owner of more than 10% of a Class of Security 133,333 $7.50 $999,998
2025-12-15 WALKER KAREN MARIE Chief Technology Officer 23,998 $4.83 $115,910
2025-12-15 WALKER KAREN MARIE Chief Technology Officer 23,998 $12.20 $292,776
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category